Details for New Drug Application (NDA): 215152
✉ Email this page to a colleague
The generic ingredient in VOQUEZNA TRIPLE PAK is amoxicillin; clarithromycin; vonoprazan fumarate. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; vonoprazan fumarate profile page.
Summary for 215152
Tradename: | VOQUEZNA TRIPLE PAK |
Applicant: | Phathom |
Ingredient: | amoxicillin; clarithromycin; vonoprazan fumarate |
Patents: | 2 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 215152
Generic Entry Date for 215152*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW Dosage:
CAPSULE, TABLET, TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Suppliers and Packaging for NDA: 215152
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VOQUEZNA TRIPLE PAK | amoxicillin; clarithromycin; vonoprazan fumarate | CAPSULE, TABLET, TABLET;ORAL | 215152 | NDA | Phathom Pharmaceuticals Inc. | 81520-255 | 81520-255-14 | 14 BLISTER PACK in 1 CARTON (81520-255-14) / 1 KIT in 1 BLISTER PACK (81520-255-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, TABLET, TABLET;ORAL | Strength | 500MG;500MG;EQ 20MG BASE | ||||
Approval Date: | May 3, 2022 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | May 3, 2032 | ||||||||
Regulatory Exclusivity Use: | GENERATING ANTIBIOTIC INCENTIVES NOW | ||||||||
Regulatory Exclusivity Expiration: | May 3, 2027 | ||||||||
Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 11, 2028 | Product Flag? | Substance Flag? | Y | Delist Request? |
Complete Access Available with Subscription